Kevin T Conroy
CIK 1306119 · President and CEO · last filed 2026-07-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$15.74M
Companies
7
Total Filings
159
Lifetime Open-Market Net
-$170.46M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ABT | Director | 133,737 | $108.62 | $14.53M | $0 | 2 | 2026-07-01 |
| ALGN | Director | 3,553 | $176.04 | $625.5K | $0 | 4 | 2026-05-22 |
| EXACT SCIENCES CORP (EXAS) Delisted | President and CEO | 0 | $104.91 | $0 | -$170.51M | 110 | 2026-03-23 |
| ADPT | Director | 22,968 | $25.45 | $584.5K | $0 | 4 | 2023-03-08 |
| Epizyme, Inc. (EPZM) Delisted | Director | 62,318 | $1.47 | $91.6K | $0 | 20 | 2022-07-05 |
| SomaLogic, Inc. (SLGCW) Delisted | Director | 25,000 | $0.09 | $2.1K | $0 | 1 | 2021-09-03 |
| THIRD WAVE TECHNOLOGIES INC /WI (TWTI) Delisted | President & CEO | 54,811 | — | — | $48.5K | 9 | 2008-05-09 |
Recent Filings · Page 7 of 16
159 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-04-01 | Epizyme, Inc. (EPZM) Delisted | Grant (A) | +1,723 | $15.0K | EDGAR |
| 2021-03-03 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +10,779 | -$1.36M | EDGAR |
| 2021-03-02 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | −21,981 | -$4.28M | EDGAR |
| 2021-02-25 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +17,905 | -$2.24M | EDGAR |
| 2021-02-23 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-18 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +15,307 | -$2.26M | EDGAR |
| 2021-02-17 | ADPT | Grant (A) | +1,504 | $0 | EDGAR |
| 2021-02-09 | EXACT SCIENCES CORP (EXAS) Delisted | Exer (M) | +17,543 | $100.0K | EDGAR |
| 2021-02-03 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | −66,094 | -$4.19M | EDGAR |
| 2021-01-07 | EXACT SCIENCES CORP (EXAS) Delisted | Sell (S) | −31,814 | -$4.10M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.